KD Pharma is a contract development and manufacturing organization (CDMO) that develops products in the pharmaceutical space by employing state-of-the-art technology. Since its inception in 1988, KD Pharma has focused on utilizing cutting edge technologies to develop and manufacture exceptional quality APIs. These twin pillars of technology and quality are the foundation of the KD Pharma CDMO Division.
The world-class c-GMP synthesis and fractionation facility in the UK has a long track record in API production. Flexible multi-purpose plants allow us to put your vision to work. KD Pharma’s specialized equipment provides development and rapid scale-up of complex, multi-step synthetic chemistry. The quality of KD Pharma products and services is reflected in the numerous certifications, successful regulatory authority inspections and customer audits achieved by the company over the last 30 years.
KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance with the FDA allow us to become your preferred CDMO solutions partner.